TABLE 1.
Characteristics of the 28 patients treated with peramivira
| Clinical characteristic | Results for patients with type A influenza |
Results for patients with type B (n = 9) | ||
|---|---|---|---|---|
| Total (n = 28)b | H1N1 pdm09 (n = 6) | H3N2 (n = 11) | ||
| Age (yr)c | 4.7 ± 4.1 (2.9, 0.6–14.8) | 4.0 ± 3.0 (4.0, 0.8–9.2) | 4.7 ± 5.0 (2.8, 0.6–14.8) | 6.0 ± 3.9 (6.6, 1.1–11.8) |
| No. of males | 17 | 3 | 6 | 6 |
| No. of vaccinationsd | 9 | 3 | 1 | 4 |
| Time after onset (h)c | 19.0 ± 20.4 (16.0, 3.0–85.5) | 32.1 ± 30.6 (22.8, 5.0–85.5) | 11.8 ± 6.8 (9.5, 3.0–22.0) | 20.3 ± 15.3 (19.3, 3.0–42.0) |
| Body temp (°C)c | 39.2 ± 0.7 (39.2, 37.7–40.3) | 39.5 ± 0.7 (39.8, 38.2–40.0) | 39.5 ± 0.5 (39.6, 39.0–40.3) | 38.9 ± 0.7 (38.6, 38.0–39.8) |
| Duration of fever (h)c | 26.9 ± 12.0 (27.0, 11.5–43.0) | 26.5 ± 14.6 (39.0, 11.5–43.0) | 27.1 ± 11.2 (27.0, 13.0–42.0) | 25.6 ± 22.7 (17.0, 5.0–66.0) |
| BUN (mg/dl)c | 12.3 ± 4.8 (11.6, 3.6–24.0) | 12.0 ± 6.7 (11.5, 3.6–24.0) | 12.5 ± 3.8 (11.6, 7.5–20.0) | 10.6 ± 2.0 (10.5, 8.0–14.0) |
| Crea (mg/dl)c | 0.3 ± 0.2 (0.3, 0.2–0.9) | 0.3 ± 0.1 (0.3, 0.3–0.4) | 0.4 ± 0.2 (0.3, 0.2–0.9) | 0.4 ± 0.1 (0.4, 0.2–0.6) |
a
There was no statistically significant difference in clinical characteristics between each group. The Steel-Dwass test was used to analyze age, hours after onset, body temperature, duration of fever, blood urea nitrogen (BUN), and creatinine (Crea); Fisher's exact test was used to analyze sex and vaccination for comparisons between each group.
b
Two patients with false-positive results on the rapid antigen test were included.
c
Data are mean ± SD (median, range).
d
Influenza vaccines were received prior to each influenza season.